Add Formweb to your mobile device
Approved Formulary
Search results for:
fosinopril
fosinopril
- Restricted Medications Non-Formulary
Brand names: Monopril
No brands, forms, or strengths have been added for this generic.
Display Angiotensin-Converting Enzyme Inhibitors Class:
243204
Medication comments:
| Per policy, orders for these non-formulary agents will be changed to formulary equivalents. | |
|---|---|
| Non-Formulary Agent | Formulary Equivalent |
| fosinopril (Monopril) 5 mg | lisinopril (Zestril, Prinivil) 5 mg |
| fosinopril (Monopril) 10 mg | lisinopril (Zestril, Prinivil) 10 mg |
| fosinopril (Monopril) 20 mg | lisinopril (Zestril, Prinivil) 20 mg |
| fosinopril (Monopril) 40 mg | lisinopril (Zestril, Prinivil) 40 mg |
| 2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults. | |
|---|---|
| Medication: | fosinopril (Monopril) |
| Criteria 4: Potentially clinically important drug-drug interactions that should be avoided in older adults. (Table 5) | |
| Interacting drug(s) or class(es) | RAS inhibitors (ACEIs ARBs, ARNIs, aliskiren) ⇄ Another RAS inhibitor or a potassium-sparing diuretic |
| Risk Rationale | Increased risk of hyperkalemia. |
| Recommendation | Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher. |
| Quality of evidence: Moderate, Strength of Recommendation: Strong | |
Last updated: Sep. 24, 2025
- Therapeutic Interchange Policy lisinopril (Zestril, Prinivil)
- Black Box Warnings Pregnancy risk